{"title":"Finite Element Method-Based Hybrid MRI/CBCT Generation to Improve Liver Stereotactic Body Radiation Therapy Targets Localization Accuracy","authors":"Zeyu Zhang;Mark Chen;Ke Lu;Dongyang Guo;Zhuoran Jiang;Hualiang Zhong;Jason Molitoris;Phuoc T. Tran;Fang-Fang Yin;Lei Ren","doi":"10.1109/TRPMS.2024.3466184","DOIUrl":null,"url":null,"abstract":"Cone-beam CT (CBCT) is commonly used in treatment imaging, but its limited soft tissue contrast presents challenges for liver tumor localization. As a result, indirect localization methods relying on the liver’s boundary are commonly utilized, which have limited accuracy for tumor localization. On-board MRI offers superior soft tissue contrast but is limited by the cost. To address this, we devised a method to generate onboard virtual MRI by integrating pretreatment MRI with onboard CBCT, enhancing liver stereotactic body radiation therapy (SBRT) tumor localization accuracy. We employed a finite element method (FEM) for deformable mapping, deforming prior liver MR images onto CBCT geometry to create a virtual MRI. This hybrid virtual-MRI/CBCT (hMRI-CBCT) approach was evaluated in a pilot study involving 48 patients. The hMRI-CBCT demonstrated superb soft-tissue contrast with clear tumor visualization. Registration accuracy of hMRI-CBCT to planning CT significantly surpasses the onboard CBCT to planning CT registration, particularly for tumors not near the liver boundary, with an average error reduction of <inline-formula> <tex-math>$1.53~\\pm ~2$ </tex-math></inline-formula>.16 mm. Our study demonstrated that hybrid MRI/CBCT can apparently reduce localization errors in liver SBRT, potentially improving tumor control and reducing toxicities, and opening avenues for further margin reduction and dose escalation.","PeriodicalId":46807,"journal":{"name":"IEEE Transactions on Radiation and Plasma Medical Sciences","volume":"9 3","pages":"372-381"},"PeriodicalIF":4.6000,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE Transactions on Radiation and Plasma Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://ieeexplore.ieee.org/document/10689493/","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Cone-beam CT (CBCT) is commonly used in treatment imaging, but its limited soft tissue contrast presents challenges for liver tumor localization. As a result, indirect localization methods relying on the liver’s boundary are commonly utilized, which have limited accuracy for tumor localization. On-board MRI offers superior soft tissue contrast but is limited by the cost. To address this, we devised a method to generate onboard virtual MRI by integrating pretreatment MRI with onboard CBCT, enhancing liver stereotactic body radiation therapy (SBRT) tumor localization accuracy. We employed a finite element method (FEM) for deformable mapping, deforming prior liver MR images onto CBCT geometry to create a virtual MRI. This hybrid virtual-MRI/CBCT (hMRI-CBCT) approach was evaluated in a pilot study involving 48 patients. The hMRI-CBCT demonstrated superb soft-tissue contrast with clear tumor visualization. Registration accuracy of hMRI-CBCT to planning CT significantly surpasses the onboard CBCT to planning CT registration, particularly for tumors not near the liver boundary, with an average error reduction of $1.53~\pm ~2$ .16 mm. Our study demonstrated that hybrid MRI/CBCT can apparently reduce localization errors in liver SBRT, potentially improving tumor control and reducing toxicities, and opening avenues for further margin reduction and dose escalation.